BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Trichostatin A
,
rs2476601
,
ZBTB7A
,
Apoptosis
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bu224
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic con…
Discriminative stimulus effects of the imidazoline I2 receptor ligands BU224 and phenyzoline in rats…
Gender difference in epileptogenic effects of 2-BFI and BU224 in mice.
Antinociceptive effects of imidazoline I2 receptor agonists in the formalin test in rats.
Discriminative stimulus effects of the novel imidazoline I₂ receptor ligand CR4056 in rats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for bu224
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ